Purchase Order 75N95019P00387
Award Date 6/24/19
Potential Completion Date 8/30/19
Potential Value $18K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Gaithersburg, MD 20879, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $29,400 firm fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the National Institutes of Health (NIH), to Dexorgen Inc., doing business as Codex Biosolutions Inc. Codex Biosolutions is a minority-owned, small disadvantaged business that specializes in advanced biotechnological research, particularly in cell line development, genetic engineering, and translational science support. The contract,...
- This contract was awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences to Codex Biosolutions Inc., a minority-owned small business located in Gaithersburg, Maryland. The $18,060 firm fixed-price purchase order is for screening services to identify small molecule antagonists of the GPR17 receptor, which is involved in various diseases. Codex Biosolutions specializes in cell-based assays and has received numerous NIH contracts for research and...
- This contract was awarded by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases to Codex Biosolutions Inc., a minority-owned small disadvantaged business, to identify cellular factors that impact the production of a full-length HIV-1 envelope trimer without altering its native antigenic properties. The $599,424.00 firm-fixed-price contract is funded through the Small Business Innovation Research (SBIR) program and...
- This is a $13,200 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the National Institutes of Health (NIH), to Dexorgen Inc., doing business as Codex Biosolutions Inc. The contract is for the development and optimization of antagonist assays in cells expressing different variants of the ACVR1 gene. Codex Biosolutions is a minority-owned small disadvantaged business located in Gaithersburg, Maryland that...
- The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $25,000 firm fixed price purchase order to Codex Biosolutions Inc., located in Gaithersburg, Maryland. Codex Biosolutions will provide research and development services under the award, which runs from September 1, 2023 through August 31, 2024. As the prime contractor, Codex Biosolutions will leverage its expertise to support the National Center for...
- Codex Biosolutions Inc. Research and Development Division, doing business as Codex Biosolutions Inc., has been awarded a $18,400 firm fixed-price purchase order by the National Institutes of Health's National Center for Advancing Translational Sciences to provide cell line generation services. The contract has a period of performance of September 1, 2023 through August 31, 2024 and will be performed in Gaithersburg, Maryland. No set-aside designation or subcontractors were indicated. The award...
- This federal contract award to Dexorgen Inc., doing business as Codex Biosolutions Inc., was issued by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the National Institutes of Health (NIH). The $24,000.00 firm-fixed price purchase order is for the "GENERATION AND CHARACTERIZATION IPSC DERIVED BRAIN ORGANOIDS FROM BAIN TYPE X-LINKED MENTAL RETARDATION SYNDROME (MRXSB)". Codex Biosolutions is a minority-owned small disadvantaged business that...
- Codex Biosolutions Inc. has been awarded a firm fixed price purchase order valued at $22,620 by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health within the Department of Health and Human Services, to deliver an EXPI293 stable cell line overexpressing HTLV envelope protein in support of NIAID's efforts to develop treatments and preventions for infectious diseases. The research and development will be conducted by Codex...
- The Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development awarded Codex Biosolutions Inc., a small disadvantaged and minority-owned business, a firm fixed-price Small Business Innovation Research (SBIR) Phase I contract for the "DEVELOPMENT OF NOVEL PDE4B INHIBITORS TO TREAT ALCOHOL USE DISORDER" worth $224,656.00. As the prime contractor, Codex Biosolutions will provide specialized bioengineering, genomic...
- This federal contract award with ID 75N95020P00247 was issued by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services' National Institutes of Health (NIH), to 10X Genomics, Inc., a small business, for the procurement of reagents for single-cell RNA sequencing analysis experiments. The $49,776.00 firm-fixed price purchase order is supporting the agency's research efforts related to the Coronavirus COVID-19 national emergency. The award...